United States · FDA National Drug Code directory
CYCLOBENZAPRINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 52817-332_56cbf625-9666-f0bd-e063-6294a90a04f1
- Product NDC
- 52817-332
- Form
- TABLET, FILM COATED
- Composition / generic term
- cyclobenzaprine hydrochloride
- Labeler
- TruPharma LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20170531
- Source listing expiry
- 20271231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET, FILM COATED in 1 BOTTLE (52817-332-00) · 52817-332-00
- 100 TABLET, FILM COATED in 1 BOTTLE (52817-332-10) · 52817-332-10
- 500 TABLET, FILM COATED in 1 BOTTLE (52817-332-50) · 52817-332-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →